Cargando…

Aetiology and presentation of childhood pleural infections in the post-pneumococcal conjugate vaccine era in South Africa

BACKGROUND: Complications of respiratory infections including pleural effusion (PE) are associated with a high morbidity. Differentiating between PE caused by Mycobacterium tuberculosis (Mtb) infection and other bacterial infections in endemic areas is difficult in children, thus, impacting treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Golden, L, Chaya, S, Reichmuth, K, Visagie, A, Ayuk, A, Kwarteng Owusu, S, Marangu, D, Affendi, N, Lakhan, A, Gray, D, Vanker, A, Zar, H, Zampoli, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: South African Medical Association 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948474/
https://www.ncbi.nlm.nih.gov/pubmed/35359691
http://dx.doi.org/10.7196/AJTCCM.2021.v27i4.152
_version_ 1784674667034836992
author Golden, L
Chaya, S
Reichmuth, K
Visagie, A
Ayuk, A
Kwarteng Owusu, S
Marangu, D
Affendi, N
Lakhan, A
Gray, D
Vanker, A
Zar, H
Zampoli, M
author_facet Golden, L
Chaya, S
Reichmuth, K
Visagie, A
Ayuk, A
Kwarteng Owusu, S
Marangu, D
Affendi, N
Lakhan, A
Gray, D
Vanker, A
Zar, H
Zampoli, M
author_sort Golden, L
collection PubMed
description BACKGROUND: Complications of respiratory infections including pleural effusion (PE) are associated with a high morbidity. Differentiating between PE caused by Mycobacterium tuberculosis (Mtb) infection and other bacterial infections in endemic areas is difficult in children, thus, impacting treatment. OBJECTIVES: To investigate the aetiology of PE and features distinguishing tuberculosis (TB) from bacterial PE in children. METHODS: We conducted a prospective study in children with PE admitted to a tertiary hospital in Cape Town from December 2017 to December 2019. Clinical information and routine laboratory investigations were compared between children with bacterial, Mtb or unclassified PE, categorised according to study definitions. RESULTS: A total of 91 patients were included in the present study and their median age was 31 months (interquartile range (IQR) 11.8 - 102.1). The aetiology was bacterial in 40% (n=37), Mtb in 39% (n=36) and unclassified in 20% (n=18) of patients. Staphylococcus aureus was the most common bacterial isolate, confirmed in 65% (n=24/37) patients, and Streptococcus pneumoniae was confirmed in only 8% of patients. TB was microbiologically confirmed in 33% (n=12/36) of patients. Patients with TB were older (91.6 v. 11.8 months; p<0.001), with more weight loss (28 v. 12 patients; p<0.001), and longer cough duration (10 v. 4 days; p<0.001) than those with other bacterial PE. In contrast, the latter had significantly higher serum C-reactive protein (median 250 v. 122 mg/L; p<0.001), procalcitonin (11 v. 0.5 mg/L; p<0.001), pleural fluid lactate dehydrogenase (7 280 v. 544 U/L; p<0.001), and adenosine deaminase levels (162 v. 48 U/L; p<0.001) and lower glucose levels (1.3 v. 4 mmol/L; p<0.001). CONCLUSION: Post 13-valent pneumococcal conjugate vaccine, S. aureus is the dominant cause of PE in children using traditional culture methods, while Mtb remains a common cause of PE in our setting. Useful clinical and laboratory differences between Mtb and other bacterial PE were identified, but the cause of PE in 20% of children was underdetermined. Molecular testing of pleural fluid for respiratory pathogens may be useful in such children.
format Online
Article
Text
id pubmed-8948474
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher South African Medical Association
record_format MEDLINE/PubMed
spelling pubmed-89484742022-03-30 Aetiology and presentation of childhood pleural infections in the post-pneumococcal conjugate vaccine era in South Africa Golden, L Chaya, S Reichmuth, K Visagie, A Ayuk, A Kwarteng Owusu, S Marangu, D Affendi, N Lakhan, A Gray, D Vanker, A Zar, H Zampoli, M Afr J Thorac Crit Care Med Research BACKGROUND: Complications of respiratory infections including pleural effusion (PE) are associated with a high morbidity. Differentiating between PE caused by Mycobacterium tuberculosis (Mtb) infection and other bacterial infections in endemic areas is difficult in children, thus, impacting treatment. OBJECTIVES: To investigate the aetiology of PE and features distinguishing tuberculosis (TB) from bacterial PE in children. METHODS: We conducted a prospective study in children with PE admitted to a tertiary hospital in Cape Town from December 2017 to December 2019. Clinical information and routine laboratory investigations were compared between children with bacterial, Mtb or unclassified PE, categorised according to study definitions. RESULTS: A total of 91 patients were included in the present study and their median age was 31 months (interquartile range (IQR) 11.8 - 102.1). The aetiology was bacterial in 40% (n=37), Mtb in 39% (n=36) and unclassified in 20% (n=18) of patients. Staphylococcus aureus was the most common bacterial isolate, confirmed in 65% (n=24/37) patients, and Streptococcus pneumoniae was confirmed in only 8% of patients. TB was microbiologically confirmed in 33% (n=12/36) of patients. Patients with TB were older (91.6 v. 11.8 months; p<0.001), with more weight loss (28 v. 12 patients; p<0.001), and longer cough duration (10 v. 4 days; p<0.001) than those with other bacterial PE. In contrast, the latter had significantly higher serum C-reactive protein (median 250 v. 122 mg/L; p<0.001), procalcitonin (11 v. 0.5 mg/L; p<0.001), pleural fluid lactate dehydrogenase (7 280 v. 544 U/L; p<0.001), and adenosine deaminase levels (162 v. 48 U/L; p<0.001) and lower glucose levels (1.3 v. 4 mmol/L; p<0.001). CONCLUSION: Post 13-valent pneumococcal conjugate vaccine, S. aureus is the dominant cause of PE in children using traditional culture methods, while Mtb remains a common cause of PE in our setting. Useful clinical and laboratory differences between Mtb and other bacterial PE were identified, but the cause of PE in 20% of children was underdetermined. Molecular testing of pleural fluid for respiratory pathogens may be useful in such children. South African Medical Association 2021-12-31 /pmc/articles/PMC8948474/ /pubmed/35359691 http://dx.doi.org/10.7196/AJTCCM.2021.v27i4.152 Text en https://creativecommons.org/licenses/by-nc/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution - NonCommercial Works License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Golden, L
Chaya, S
Reichmuth, K
Visagie, A
Ayuk, A
Kwarteng Owusu, S
Marangu, D
Affendi, N
Lakhan, A
Gray, D
Vanker, A
Zar, H
Zampoli, M
Aetiology and presentation of childhood pleural infections in the post-pneumococcal conjugate vaccine era in South Africa
title Aetiology and presentation of childhood pleural infections in the post-pneumococcal conjugate vaccine era in South Africa
title_full Aetiology and presentation of childhood pleural infections in the post-pneumococcal conjugate vaccine era in South Africa
title_fullStr Aetiology and presentation of childhood pleural infections in the post-pneumococcal conjugate vaccine era in South Africa
title_full_unstemmed Aetiology and presentation of childhood pleural infections in the post-pneumococcal conjugate vaccine era in South Africa
title_short Aetiology and presentation of childhood pleural infections in the post-pneumococcal conjugate vaccine era in South Africa
title_sort aetiology and presentation of childhood pleural infections in the post-pneumococcal conjugate vaccine era in south africa
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8948474/
https://www.ncbi.nlm.nih.gov/pubmed/35359691
http://dx.doi.org/10.7196/AJTCCM.2021.v27i4.152
work_keys_str_mv AT goldenl aetiologyandpresentationofchildhoodpleuralinfectionsinthepostpneumococcalconjugatevaccineerainsouthafrica
AT chayas aetiologyandpresentationofchildhoodpleuralinfectionsinthepostpneumococcalconjugatevaccineerainsouthafrica
AT reichmuthk aetiologyandpresentationofchildhoodpleuralinfectionsinthepostpneumococcalconjugatevaccineerainsouthafrica
AT visagiea aetiologyandpresentationofchildhoodpleuralinfectionsinthepostpneumococcalconjugatevaccineerainsouthafrica
AT ayuka aetiologyandpresentationofchildhoodpleuralinfectionsinthepostpneumococcalconjugatevaccineerainsouthafrica
AT kwartengowusus aetiologyandpresentationofchildhoodpleuralinfectionsinthepostpneumococcalconjugatevaccineerainsouthafrica
AT marangud aetiologyandpresentationofchildhoodpleuralinfectionsinthepostpneumococcalconjugatevaccineerainsouthafrica
AT affendin aetiologyandpresentationofchildhoodpleuralinfectionsinthepostpneumococcalconjugatevaccineerainsouthafrica
AT lakhana aetiologyandpresentationofchildhoodpleuralinfectionsinthepostpneumococcalconjugatevaccineerainsouthafrica
AT grayd aetiologyandpresentationofchildhoodpleuralinfectionsinthepostpneumococcalconjugatevaccineerainsouthafrica
AT vankera aetiologyandpresentationofchildhoodpleuralinfectionsinthepostpneumococcalconjugatevaccineerainsouthafrica
AT zarh aetiologyandpresentationofchildhoodpleuralinfectionsinthepostpneumococcalconjugatevaccineerainsouthafrica
AT zampolim aetiologyandpresentationofchildhoodpleuralinfectionsinthepostpneumococcalconjugatevaccineerainsouthafrica